NASDAQ : BLCM

Bellicum Pharmaceuticals, Inc.

$0.07475 USD

-$0.01 (-6.62%)

Volume
6.06K
Average Volume
27.95K
Market Capitalization
$778.33K
P/E Ratio
-0.09
Dividend Yield
0.00%
Price Target
Year High
$1.31
Year Low
$0.06
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.31
Company Overview

NASDAQ

David M. Maggio

Biotechnology

Healthcare

BLCM

13

US

USD

https://www.bellicum.com

281 454 3424

079481404

0001358403

Liquidity Metrics

0.00

6.31

6.31

5.79

0.00

Sales & Valuation

$1.5M

0.52

1.14

-0.03

-0.84

Profitability

-$0.81

-$24.97M

-1664.87%

-1664.73%

-189.12%

-104.83%

P/E Metrics

-0.09

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

9 Analysts

%

Poll Results

About Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Stock

Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lympho ... mas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.

Frequently Asked Questions

What is the current Bellicum Pharmaceuticals, Inc. (BLCM) stock price?

Bellicum Pharmaceuticals, Inc.(NASDAQ:BLCM) stock price is $0.07475 in the last trading session. During the trading session, BLCM stock reached the peak price of $1.31 while $0.06 was the lowest point it dropped to. The percentage change in BLCM stock occurred in the recent session was --6.62% while the dollar amount for the price change in BLCM stock was -$0.01.

BLCM's industry and sector of operation?

The NASDAQ listed BLCM is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of BLCM?

Alan K. Smith | Chief Scientific Officer
Joseph Senesac | Senior Vice President of Technical Operations & Quality
Charles S. Grass | Principal Accounting Officer
David Maggio | Chief Executive Officer
|

How many employees does BLCM have?

Number of BLCM employees currently stands at 13. BLCM operates from 3730 Kirby Drive, Houston, TX 77098, US.

Link for BLCM official website?

Official Website of BLCM is: https://www.bellicum.com

How do I contact BLCM?

BLCM could be contacted at phone #281 454 3424 and can also be accessed through its website. BLCM operates from 3730 Kirby Drive, Houston, TX 77098, US.

How many shares of BLCM are traded daily?

The average number of BLCM shares traded daily for last 3 months was 27.95K.

What is the market cap of BLCM currently?

The market value of BLCM currently stands at $778.33K with its latest stock price at $0.07475